SCHEMBL4244154

SCHEMBL4244154

COC(=O)c1ccc(CN(CCCN(Cc2ccc(C(=O)O)cc2)C(=O)OCc2cncs2)C(=O)OCc2cncs2)cc1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.49
CYP2D6 P10635 3/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
TDP1 Q9NUW8 1/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LPAR1 Q92633 2/20 0.38
LPAR5 Q9H1C0 2/20 0.38
LMNA P02545 1/20 0.38
PARP15 Q460N3 1/20 0.37
PARP10 Q53GL7 1/20 0.37
CYP4A11 Q02928 2/20 0.37
CYP4F2 P78329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL893411 0.96 CYP3A4 (0.50) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL9943481 0.94 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL9943899 0.90 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL893151 0.90 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL4252360 0.85 CYP3A4 (0.49) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL893098 0.85 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL4390638 0.84 CYP3A4 (0.51) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL893530 0.84 CYP3A4 (0.52) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL893829 0.83 CYP3A4 (0.49) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL4248044 0.83 CYP3A4 (0.57) CYP3A4CYP2D6CYP2C9CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465856-A2 Cytochrome P450 oxidase inhibitors and uses thereof Abbott Laboratories (US) 2012-06-20 EP claimed
EP-2081917-A2 CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF Abbott Laboratories (US) 2009-07-29 EP claimed
WO-2008027932-A2 CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF ABBOTT LABORATORIES (US) 2008-03-06 WO claimed
EP-2465856-A2 Cytochrome P450 oxidase inhibitors and uses thereof Abbott Laboratories (US) 2012-06-20 EP disclosed
EP-2465855-A1 Cytochrome P450 oxidase inhibitors and uses thereof Abbott Laboratories (US) 2012-06-20 EP disclosed
EP-2081917-A2 CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF Abbott Laboratories (US) 2009-07-29 EP disclosed
WO-2008027932-A2 CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF ABBOTT LABORATORIES (US) 2008-03-06 WO disclosed